Lista_2022_Ageing.Res.Rev__101819

Reference

Title : Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases - Lista_2022_Ageing.Res.Rev__101819
Author(s) : Lista S , Vergallo A , Teipel SJ , Lemercier P , Giorgi FS , Gabelle A , Garaci F , Mercuri NB , Babiloni C , Gaire BP , Koronyo Y , Koronyo-Hamaoui M , Hampel H , Nistico R
Ref : Ageing Res Rev , :101819 , 2022
Abstract : Lista_2022_Ageing.Res.Rev__101819
ESTHER : Lista_2022_Ageing.Res.Rev__101819
PubMedSearch : Lista_2022_Ageing.Res.Rev__101819
PubMedID: 36526257

Related information

Citations formats

Lista S, Vergallo A, Teipel SJ, Lemercier P, Giorgi FS, Gabelle A, Garaci F, Mercuri NB, Babiloni C, Gaire BP, Koronyo Y, Koronyo-Hamaoui M, Hampel H, Nistico R (2022)
Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases
Ageing Res Rev :101819

Lista S, Vergallo A, Teipel SJ, Lemercier P, Giorgi FS, Gabelle A, Garaci F, Mercuri NB, Babiloni C, Gaire BP, Koronyo Y, Koronyo-Hamaoui M, Hampel H, Nistico R (2022)
Ageing Res Rev :101819